FDA chief outlines new ways to speed cancer drug approvals – CNBC
pharmaphorum |
FDA chief outlines new ways to speed cancer drug approvals
CNBC The U.S. Food and Drug Administration is taking steps to streamline the approval process for cancer drugs, reviewing clinical trial data up front to make sure … ASCO round up: Bluebird bio’s CAR–T shines, plus blood tests for lung cancerpharmaphorum |
Sky News |
Prostate cancer immune system drug results could be ‘spectacular …
BBC News Drugs that boost the immune system have saved the lives of some men with terminal prostate cancer, say doctors in the UK. The team at the Institute of Cancer … Immunotherapy prostate cancer drug gives ‘amazing results’Sky News ASCO 2018: Major trial is first to show benefits of immunotherapy in some men with prostate cancerThe Institute of Cancer Research Immunotherapy working on prostate cancerSBS |
pharmaphorum |
ASCO round up: Bluebird bio’s CAR–T shines, plus blood tests for lung cancer
pharmaphorum The results from the therapy known as bb2121 are closely watched as it has a different mechanism of action than the two already approved CAR-Ts from Gilead and Kite. Bluebird’s CAR-T (chimeric antigen-receptor T–cell) therapy works by targeting B-cell … FDA chief outlines new ways to speed cancer drug approvalsCNBC |
The Guardian |
Immunotherapy could stop prostate cancer spreading, trial shows
The Guardian Men with otherwise untreatable prostate cancer could halt its spread and survive longer by undergoing immunotherapy treatment, a trial has shown. More than a third of men with an advanced form of the cancer were still alive and one-in-10 had not had … Prostate cancer immune system drug results could be ‘spectacular’BBC News ASCO 2018: Major trial is first to show benefits of immunotherapy in some men with prostate cancerThe Institute of Cancer Research Prostate cancer breakthrough as new drug keeps men with previously ‘untreatable’ cases aliveTelegraph.co.uk |
The Guardian |
Immunotherapy could stop prostate cancer spreading, trial shows
The Guardian Men with otherwise untreatable prostate cancer could halt its spread and survive longer by undergoing immunotherapy treatment, a trial has shown. More than a third of men with an advanced form of the cancer were still alive and one-in-10 had not had … Prostate cancer immune system drug results could be ‘spectacular’BBC News ASCO 2018: Major trial is first to show benefits of immunotherapy in some men with prostate cancerThe Institute of Cancer Research Prostate cancer breakthrough as new drug keeps men with previously ‘untreatable’ cases aliveTelegraph.co.uk |